Cocaine esterase prevents cocaine-induced toxicity and the ongoing intravenous self-administration of cocaine in rats

Journal of Pharmacology and Experimental Therapeutics

Volumn 331, Issue 2, 2009, Pages 445-455

  Collins, Gregory T ^a   Brim, Remy L ^a   Narasimhan, Diwahar ^a   Ko, Mei Chuan ^a   Sunahara, Roger K ^a   Zhan, Chang Guo ^b   Woods, James H ^a  

^a UNIVERSITY OF MICHIGAN MEDICAL SCHOOL   (United States)

^b University of Kentucky   (United States)

Author keywords

[No Author keywords available]

Indexed keywords

CARBOXYLESTERASE; COCAINE; SODIUM CHLORIDE; TROPARIL;

ANIMAL EXPERIMENT; ANIMAL MODEL; ARTICLE; CONTROLLED STUDY; CONVULSION; DOSE RESPONSE; DRUG ABUSE; DRUG EFFECT; DRUG SELF ADMINISTRATION; LETHALITY; MALE; NONHUMAN; PRIORITY JOURNAL; RAT; REINFORCEMENT;

ANIMALS; CARBOXYLIC ESTER HYDROLASES; COCAINE; COCAINE-RELATED DISORDERS; CONDITIONING, OPERANT; DOPAMINE UPTAKE INHIBITORS; DOSE-RESPONSE RELATIONSHIP, DRUG; MALE; RATS; RATS, SPRAGUE-DAWLEY; SEIZURES; SELF ADMINISTRATION; SUBSTANCE ABUSE, INTRAVENOUS;

EID: 70350459860     PISSN: 00223565     EISSN: 15210103     Source Type: Journal    
DOI: 10.1124/jpet.108.150029     Document Type: Article

References (28)

1. Baird TJ, Deng SX, Landry DW, Winger G, and Woods JH (2000) Natural and artificial enzymes against cocaine. I. Monoclonal antibody 15A10 and the reinforcing effects of cocaine in rats. J Pharmacol Exp Ther 295:1127-1134. (Pubitemid 30951572)
2. Brimijoin S, Gao Y, Anker JJ, Gliddon LA, Lafleur D, Shah R, Zhao Q, Singh M, and Carroll ME (2008) A cocaine hydrolase engineered from human butyrylcholinesterase selectively blocks cocaine toxicity and reinstatement of drug seeking in rats. Neuropsychopharmacology 33:2715-2725.
3. Carrera MR, Ashley JA, Zhou B, Wirsching P, Koob GF, and Janda KD (2000) Cocaine vaccines: antibody protection against relapse in a rat model. Proc Natl Acad Sci U S A 97:6202-6206. (Pubitemid 30367547)
4. Carroll FI, Howard JL, Howell LL, Fox BS, and Kuhar MJ (2006) Development of the dopamine transporter selective RTI-336 as a pharmacotherapy for cocaine abuse. AAPS J 8:E196-E203.
5. Cooper ZD, Narasimhan D, Sunahara RK, Mierzejewski P, Jutkiewicz EM, Larsen NA, Wilson IA, Landry DW, and Woods JH (2006) Rapid and robust protection against cocaine-induced lethality in rats by the bacterial cocaine esterase. Mol Pharmacol 70:1885-1891. (Pubitemid 44771904)
6. Dackis C and O'Brien C (2003) Glutamatergic agents for cocaine dependence. Ann N Y Acad Sci 1003:328-345.
7. Fox BS, Kantak KM, Edwards MA, Black KM, Bollinger BK, Botka AJ, French TL, Thompson TL, Schad VC, Greenstein JL, et al. (1996) Efficacy of a therapeutic cocaine vaccine in rodent models. Nat Med 2:1129-1132. (Pubitemid 26338633)
8. Gao D, Narashimhan DL, Macdonald J, Brim R, Ko MC, Landry DW, Woods JH, Sunahara R, and Zhan CG (2009) Thermostable variants of cocaine esterase for long-time protection against cocaine toxicity. Mol Pharmacol 75:318-323.
9. Grabowski J, Shearer J, Merrill J, and Negus SS (2004) Agonist-like, replacement pharmacotherapy for stimulant abuse and dependence. Addict Behav 29:1439-1464. (Pubitemid 39172183)
10. Institute of Laboratory Animal Resources (1996) Guide for the Care and Use of Laboratory Animals, 7th ed. Institute of Laboratory Animal Resources, Commission on Life Sciences, National Research Council, Washington, DC.
11. Jutkiewicz EM, Baladi MG, Cooper ZD, Narasimhan D, Sunahara RK, and Woods JH (2009) A bacterial cocaine esterase protects against cocaine-induced epileptogenic activity and lethality. Ann Emerg Med 54:409-420.
12. Kantak KM, Collins SL, Lipman EG, Bond J, Giovanoni K, and Fox BS (2000) Evaluation of anti-cocaine antibodies and a cocaine vaccine in a rat self-administration model. Psychopharmacology (Berl) 148:251-262. (Pubitemid 30136732)
13. Ko MC, Bowen LD, Narasimhan D, Berlin AA, Lukacs NW, Sunahara RK, Cooper ZD, and Woods JH (2007) Cocaine esterase: interactions with cocaine and immune responses in mice. J Pharmacol Exp Ther 320:926-933. (Pubitemid 46147977)
14. Kosten T, Martell B, Poling J, and Gardner T (2008) Cocaine vaccine: 6-month follow-up during drop in antibody levels (abstract 394); College on Problems of Drug Dependence Annual Meeting; 2008 June 14-18; San Juan, Puerto Rico.
15. Kosten TR, Rosen M, Bond J, Settles M, Roberts JS, Shields J, Jack L, and Fox B (2002) Human therapeutic cocaine vaccine: safety and immunogenicity. Vaccine 20:1196-1204. (Pubitemid 34135957)
16. Landry DW and Yang GX (1997) Anti-cocaine catalytic antibodies-a novel approach to the problem of addiction. J Addict Dis 16:1-17.
17. Landry DW, Zhao K, Yang GX, Glickman M, and Georgiadis TM (1993) Antibody-catalyzed degradation of cocaine. Science 259:1899-1901.
18. Larsen NA, Turner JM, Stevens J, Rosser SJ, Basran A, Lerner RA, Bruce NC, and Wilson IA (2002) Crystal structure of a bacterial cocaine esterase. Nat Struct Biol 9:17-21. (Pubitemid 34049173)
19. Martell BA, Mitchell E, Poling J, Gonsai K, and Kosten TR (2005) Vaccine pharmacotherapy for the treatment of cocaine dependence. Biol Psychiatry 58:158-164. (Pubitemid 41008133)
20. Mello NK (1990) Preclinical evaluation of the effects of buprenorphine, naltrexone and desipramine on cocaine self-administration. NIDA Res Monogr 105:189-195.
21. Mets B, Winger G, Cabrera C, Seo S, Jamdar S, Yang G, Zhao K, Briscoe RJ, Almonte R, Woods JH, et al. (1998) A catalytic antibody against cocaine prevents cocaine's reinforcing and toxic effects in rats. Proc Natl Acad Sci U S A 95:10176-10181. (Pubitemid 28415314)
22. Newman AH, Grundt P, and Nader MA (2005) Dopamine D3 receptor partial agonists and antagonists as potential drug abuse therapeutic agents. J Med Chem 48:3663-3679. (Pubitemid 40776839)
23. Pan Y, Gao D, Yang W, Cho H, Yang G, Tai HH, and Zhan CG (2005) Computational redesign of human butyrylcholinesterase for anticocaine medication. Proc Natl Acad Sci U S A 102:16656-16661. (Pubitemid 41688832)
24. Platt DM, Rowlett JK, and Spealman RD (2002) Behavioral effects of cocaine and dopaminergic strategies for preclinical medication development. Psychopharmacology (Berl) 163:265-282.
25. Roberts DC and Brebner K (2000) GABA modulation of cocaine self-administration. Ann N Y Acad Sci 909:145-158.
26. Rothman RB, Baumann MH, Prisinzano TE, and Newman AH (2008) Dopamine transport inhibitors based on GBR12909 and benztropine as potential medications to treat cocaine addiction. Biochem Pharmacol 75:2-16.
27. Substance Abuse and Mental Health Services Administration (SAMHSA) (2007) Results from the 2006 National Survey on Drug Use and Health: National Findings. Office of Applied Studies, NSDUH Series H-32, DHHS Publication No. SMA 07-4293. SAMHSA, Rockville, MD.
28. Turner JM, Larsen NA, Basran A, Barbas CF III, Bruce NC, Wilson IA, and Lerner RA (2002) Biochemical characterization and structural analysis of a highly proficient cocaine esterase. Biochemistry 41:12297-12307.